PHARMACY-PHARMACEUTICS Course Descriptions | MSB 100 | 392-3405 | UNDERGRADUATE ADVISER(S): M. MCKENZIE, G. BRAZEAU, J. HUGHES | GRADUATE ADVISER: G. HOCHHAUS, L. PROKAI | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DEPT-CRSE | CF | CC | GE | REQ | SECT | CRED | -DAY(S)- | PERIOD | BLDG | ROOM | EXAM | ||
PHA 4905 | X | 6555X | VAR | TBA | PROB IN PHARMACEUTICS | DERENDORF | |||||||
PHA 5100 | X | 3647X | 03 | M W F | 2 | FE | DOSAGE FORMS 1 | PROKAI | |||||
M | 8 | ||||||||||||
PHA 5100 | X | 4999X | 03 | M W F | 2 | FE | DOSAGE FORMS 1 | PROKAI | |||||
M | 8 | ||||||||||||
PHA 5100 | X | 5000X | 03 | M W F | 2 | FE | DOSAGE FORMS 1 | PROKAI | |||||
M | 8 | ||||||||||||
PHA 5100 | X | 5001X | 03 | M W F | 2 | FE | DOSAGE FORMS 1 | PROKAI | |||||
M | 8 | ||||||||||||
PHA 5100 | X | 5002X | 03 | M W F | 2 | FE | DOSAGE FORMS 1 | PROKAI | |||||
M | 9 | ||||||||||||
PHA 5100 | X | 5003X | 03 | M W F | 2 | FE | DOSAGE FORMS 1 | PROKAI | |||||
M | 9 | ||||||||||||
PHA 5100 | X | 5260X | 03 | M W F | 2 | FE | DOSAGE FORMS 1 | HUGHES | |||||
M | 9 | ||||||||||||
PHA 5100 | X | 6097X | 03 | M W F | 2 | FE | DOSAGE FORMS 1 | HUGHES | |||||
M | 9 | ||||||||||||
PHA 5104 | X | 7036X | 02 | T R | 3 | FE | DOSAGE FORM/CONTEMP | HUGHES | |||||
PHA 5127 | X | 4659X | 02 | W F | 5 | FE | DOSE OPTIMIZATION 1 | HOCHHAUS | |||||
PHA 5171 | X | 5938X | 03 | TBA | NFE | PHARMACEU BIOTECH | HUGHES | ||||||
PHA 5933 | X | DEP-X | 01 | TBA | NFE | SELECT TOP PHARMACY | HUGHES | ||||||
PHA 5933 | X | 6361X | VAR | TBA | FE | SELECT TOP PHARMACY | HUGHES | ||||||
PHA 6116 | X | 5158X | 03 | TBA | NFE | IN VIVO & IN VITRO | SCHWARTZ | ||||||
PHA 6440 | X | 3650X | 01 | TBA | FE | SEMINAR DRUG DISCOVER | PROKAI | ||||||
PHA 6938 | X | 3654X | 01 | TBA | FE | RESEARCH SEMINAR | HOCHHAUS | ||||||
PHA 7979 | X | 3657X | VAR | TBA | FE | ADVANCED RESEARCH | HOCHHAUS | ||||||
PHA 7980 | X | 3658X | VAR | TBA | FE | DOCTORAL RESEARCH | DERENDORF |